- Statement of Changes in Beneficial Ownership (4)
30 October 2009 - 7:06AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
SOFAER ABRAHAM D
|
2. Issuer Name
and
Ticker or Trading Symbol
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
[
NTII
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O NEUROBIOLOGICAL TECHNOLOGIES, INC., 2000 POWELL STREET, SUITE 800
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/27/2009
|
(Street)
EMERYVILLE, CA 94608
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
10/27/2009
|
|
M
|
|
15000
|
A
|
$0.65
|
125931
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option (Right to Buy)
|
$0.65
|
10/27/2009
|
|
M
|
|
|
15000
|
(1)
|
(2)
|
Common Stock
|
15000
|
$0
|
0
|
D
|
|
Explanation of Responses:
|
(
1)
|
The Board of Directors of the Issuer approved acceleration of the vesting of all options so that the options become exercisable upon the approval of the dissolution of the Issuer by the stockholders. The stockholders of the Issuer approved the dissolution at a special meeting of stockholders held on October 27, 2009.
|
(
2)
|
Options will be terminated on the effective date of a certificate of dissolution of the Issuer to be filed with the Secretary of State of Delaware.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
SOFAER ABRAHAM D
C/O NEUROBIOLOGICAL TECHNOLOGIES, INC.
2000 POWELL STREET, SUITE 800
EMERYVILLE, CA 94608
|
X
|
|
|
|
Signatures
|
Alicy Byrd, by power of attorney
|
|
10/29/2009
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Nov 2024 to Dec 2024
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Neurobiological Technologies (MM) (NASDAQ): 0 recent articles
More News Articles